The somatic genomics approach analyses naturally accumulated genetic mutations within individual patient tissue.

Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has entered a multi-year research collaboration agreement with Merck, known as ...

MSD is paying $20 million upfront to activate an alliance with Flagship Pioneering's Quotient Therapeutics that will focus on finding new therapeutic targets in inflammatory bowel disease (IBD). The ...

Quotient, which originated as the consumer-facing Coupons.com in the late ’90s, is pushing deeper into programmatic media. The company has launched the Quotient Media Exchange (QMX), a digital media ...

Quotient's sales are shrinking as demand dries up for digital promotions. Management is focused on cutting costs today. The jump was sparked by news that the management team is considering a sale that ...

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom. Quotient, ...

Quotient’s complete fourth quarter and full year 2021 financial results and management commentary can be found by accessing the Company’s stockholder letter under Key Resources on the overview page of ...

DALLAS, TX / ACCESS Newswire / April 2, 2026 / Quotient Wealth Partners announced a new partnership with Cariloop, a Public Benefit Corporation, to integrate comprehensive caregiver support solutions ...

Deepali Vyas is the founder of Fearless+, which connects teens with college & career opps and a new resume format building soft skills. In today's rapidly evolving and competitive world, intelligence ...